Human kinome analysis reveals novel kinases contributing to virus infection and retinoic-acid inducible gene I-induced type i and type III IFN gene expression

Innate Immunity

Volumn 19, Issue 5, 2013, Pages 516-530

  Nousiainen, Laura ^a   Sillanpää, Maarit ^a   Jiang, Miao ^a   Thompson, James ^b   Taipale, Jussi ^c   Julkunen, Ilkka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

innate immunity; interferon regulatory factor; kinase signalling; type III interferon; Viral infection

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 29; LUCIFERASE; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHOTRANSFERASE; PROTEIN KINASE FYN; PROTEIN KINASE YES; RETINOIC ACID INDUCIBLE PROTEIN I; SFRS PROTEIN KINASE 1; STK24 PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA LIBRARY; ENZYME ASSAY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; HUMAN CELL; INNATE IMMUNITY; MUTANT; ONCOGENE; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SENDAI VIRUS INFECTION; TRANSCRIPTION REGULATION;

INNATE IMMUNITY; INTERFERON REGULATORY FACTOR; KINASE SIGNALLING; TYPE III INTERFERON; VIRAL INFECTION;

ACTIVIN RECEPTORS, TYPE I; DEAD-BOX RNA HELICASES; GENE LIBRARY; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; INTERLEUKINS; MUTAGENESIS, SITE-DIRECTED; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-FYN; RESPIROVIRUS INFECTIONS; SENDAI VIRUS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 84884222297     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912473345     Document Type: Article

References (68)

1. Barber GN. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol. 2011 ; 23: 10-20
2. Kumar H. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011 ; 30: 16-16
3. Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006 ; 441: 101-105
4. Kato H, Takeuchi O, Mikamo-Satoh E, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med. 2008 ; 205: 1601-1610 (Pubitemid 351962024)
5. Jiang M, Osterlund P, Sarin LP, et al. Innate immune responses in human monocyte-derived dendritic cells are highly dependent on the size and the 5' phosphorylation of RNA molecules. J Immunol. 2011 ; 187: 1713-1721
6. Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006 ; 13: 816-825
7. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006 ; 7: 131-137 (Pubitemid 43135878)
8. Kumagai Y, Akira S. Identification and functions of pattern-recognition receptors RID C-3134-2009. J Allergy Clin Immunol. 2010 ; 125: 985-992
9. Platanias L. Mechanisms of type-I- and type-II-interferon-mediated signalling. 2005; 5: 375-386.
10. Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003 ; 4: 69-77 (Pubitemid 36109115)
11. Sheppard P, Kindsvogel W, Xu WF, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 2003 ; 4: 63-68 (Pubitemid 36104710)
12. Osterlund PI, Pietilae TE, Veckman V, et al. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol. 2007 ; 179: 3434-3442
13. Marié I, Durbin JE, Levy DE. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998 ; 17: 6660-6669 (Pubitemid 28521799)
14. Osterlund P, Veckman V, Siren J, et al. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol. 2005 ; 79: 9608-9617 (Pubitemid 41022304)
15. Onoguchi K, Yoneyama M, Takemura A, et al. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem. 2007 ; 282: 7576-7581 (Pubitemid 47093699)
16. Dumoutier L, Tounsi A, Michiels T, et al. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1 - Similarities with type I interferon signaling. J Biol Chem. 2004 ; 279: 32269-32274 (Pubitemid 39014676)
17. Siren J, Pirhonen J, Julkunen K, Matikainen S. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J Immunol. 2005 ; 174: 1932-1937 (Pubitemid 40223933)
18. Coccia EM, Severa M, Giacomini E, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol. 2004 ; 34: 796-805 (Pubitemid 39255927)
19. Berghall H, Siren J, Sarkar D, et al. The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines. Microb Infect. 2006 ; 8: 2138-2144 (Pubitemid 44311582)
20. Chi B, Dickensheets HL, Spann KM, et al. Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol. 2006 ; 80: 5032-5040
21. Spann KM, Tran KC, Collins PL. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappa B, and proinflammatory cytokines. J Virol. 2005 ; 79: 5353-5362 (Pubitemid 40548204)
22. Pietila TE, Latvala S, Osterlund P, Julkunen I. Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteria-infected human monocyte-derived DCs. J Leukoc Biol. 2010 ; 88: 665-674
23. Lebreton A, Lakisic G, Job V, et al. A Bacterial protein targets the BAHD1 Chromatin complex to stimulate type III interferon response. Science. 2011 ; 331: 1319-1321
24. Bierne H, Travier L, Mahlakõiv T, et al. Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta. PLoS One. 2012 ; 7: e39080 - e39080
25. Varjosalo M, Bjorklund M, Cheng F, et al. Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell. 2008 ; 133: 537-548 (Pubitemid 351622012)
26. Kaukinen P, Sillanpaa M, Kotenko S, et al. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virology J. 2006 ; 3: 66-66
27. Lin R, Heylbroeck C, Genin P, et al. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol. 1999 ; 19: 959-966 (Pubitemid 29046840)
28. Lin R, Genin P, Mamane Y, Hiscott J. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol. 2000 ; 20: 6342-6353 (Pubitemid 30650221)
29. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004 ; 5: 730-737 (Pubitemid 39023305)
30. Fitzgerald K, Palsson-McDermott E, Bowie A, et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction RID B-9553-2008. Nature. 2001 ; 413: 78-83 (Pubitemid 32843491)
31. Pietila TE, Veckman V, Lehtonen A, et al. Multiple NF-kappa B and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells. J Immunol. 2007 ; 178: 253-261 (Pubitemid 46033608)
32. Lin R, Heylbroeck C, Pitha P, Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol. 1998 ; 18: 2986-2996 (Pubitemid 28183468)
33. Zhang LW, Pagano JS. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Cell Biol. 1997 ; 17: 5748-5757 (Pubitemid 27411082)
34. Sharma S, tenOever BR, Grandvaux N, et al. Triggering the interferon antiviral response through an IKK-related pathway. Science. 2003 ; 300: 1148-1151 (Pubitemid 36583100)
35. Ronni T, Saraneva T, Pirhonen J, Julkunen I. Activation of IFN-Alpha, IFN-Gamma, MxA, and IFN regulatory factor-1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J Immunol. 1995 ; 154: 2764-2774
36. Veckman V, Osterlund P, Fagerlund R, et al. TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology. 2006 ; 345: 96-104 (Pubitemid 43107575)
37. Matikainen S, Siren J, Tissari J, et al. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol. 2006 ; 80: 3515-3522
38. Loo Y, Gale M. Immune signaling by RIG-I-like receptors. Immunity. 2011 ; 34: 680-692
39. Gack MU, Shin YC, Joo C, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 2007 ; 446: 916-920 (Pubitemid 46633167)
40. Kim M, Suh H, Brosnan C, Lee S. Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta. J Neurochem. 2004 ; 90: 297-308 (Pubitemid 38938215)
41. Ieki K, Matsukura S, Kokubu F, et al. Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappa B and interferon regulatory factors in human airway epithelial cells. Clin Exp Allergy. 2004 ; 34: 745-752 (Pubitemid 38736789)
42. Fitzgerald K, McWhirter S, Faia K, et al. IKK epsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 2003 ; 4: 491-496 (Pubitemid 36592443)
43. Lu T, Lai W, Huang CF, et al. Inhibition of cell migration by autophosphorylated mammalian sterile 20-like kinase 3 (MST3) involves paxillin and protein-tyrosine phosphatase-PEST. J Biol Chem. 2006 ; 281: 38405-38417 (Pubitemid 46041964)
44. Wu H, Lin C, Lin T, et al. Mammalian Ste20-like protein kinase 3 mediates trophoblast apoptosis in spontaneous delivery. Apoptosis. 2008 ; 13: 283-294 (Pubitemid 351172130)
45. Yu PB, Deng DY, Lai CS, et al. BMP type I receptor inhibition reduces heterotopic ossification. Nat Med. 2008 ; 14: 1363-1369
46. Furuya H, Ikezoe K, Wang L, et al. A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am J Med Genet. 2008 ; 146A: 459-463 (Pubitemid 351206817)
47. Kevenaar ME, Themmen APN, van Kerkwijk AJ, et al. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome. Hum Reprod. 2009 ; 24: 241-249
48. Gui J, Lane W, Fu X. A serine kinase regulates intracellular-localization of splicing factors in the cell cycle. Nature. 1994 ; 369: 678-682 (Pubitemid 24199476)
49. Wang H, Lin W, Dyck J, et al. SRPK2: A differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. J Cell Biol. 1998 ; 140: 737-750 (Pubitemid 28141214)
50. Hayes GM, Carrigan PE, Miller LJ. Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. Cancer Res. 2007 ; 67: 2072-2080 (Pubitemid 46424225)
51. Bell I, Martin A, Roberts S. The E1 boolean AND E4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1. J Virol. 2007 ; 81: 5437-5448 (Pubitemid 46846985)
52. Salmond RJ, Filby A, Qureshi I, et al. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev. 2009 ; 228: 9-22
53. Phipps D, Yousefi S, Branch D. Increased enzymatic activity of the T-cell antigen receptor-associated Fyn protein tyrosine kinase in asymptomatic patients infected with the human immunodeficiency virus. Blood. 1997 ; 90: 3603-3612 (Pubitemid 27473430)
54. Barua D, Hlavacek WS, Lipniacki T. A computational model for early events in B cell antigen receptor signaling: analysis of the roles of Lyn and Fyn. J Immunol. 2012 ; 189: 646-658
55. Shelton H, Harris M. Hepatitis C virus NS5A protein binds the SH3 domain of the Fyn tyrosine kinase with high affinity: mutagenic analysis of residues within the SH3 domain that contribute to the interaction. Virol J. 2008 ; 5: 24-24
56. Supekova L, Supek F, Lee J, et al. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. J Biol Chem. 2008 ; 283: 29-36
57. Johnsen IB, Nguyen TT, Bergstroem B, et al. The tyrosine kinase c-Src Enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling. J Biol Chem. 2009 ; 284: 19122-19131
58. Yamashita M, Chattopadhyay S, Fensterl V, et al. A TRIF-independent branch of TLR3 signaling. J Immunol. 2012 ; 188: 2825-2833
59. Smolinska MJ, Page TH, Urbaniak AM, et al. Hck Tyrosine kinase regulates TLR4-induced TNF and IL-6 production via AP-1. J Immunol. 2011 ; 187: 6043-6051
60. Kotenko SV. IFN-lambda s. Curr Opin Immunol. 2011 ; 23: 583-590
61. Okabayashi T, Kojima T, Masaki T, et al. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res. 2011 ; 160: 360-366
62. Mordstein M, Pott J, Mahlakoiv T, et al. A non-redundant role of IFN-lambda in antiviral defense of the intestinal tract. Cytokine. 2010 ; 52: 48-48
63. Yoshikawa T, Hill TE, Yoshikawa N, et al. Dynamic Innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS One. 2010 ; 5: e8729 - e8729
64. Mordstein M, Kochs G, Dumoutier L, et al. Interferon-lambda contributes to innate immunity of mice against influenza a virus but not against hepatotropic viruses. Cytokine. 2008 ; 4: e1000151 - e1000151
65. Wang J, Oberley-Deegan R, Wang S, et al. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol. 2009 ; 182: 1296-1304
66. Pott J, Mahlakoiv T, Mordstein M, et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci USA. 2011 ; 108: 7944-7949
67. Joerg W, Sabine Z, Thomas T. Functional impact of type III IFNs (IFN lambda, IL28/IL29) in cutaneous lupus erythematosus. Cytokine. 2011 ; 56: 88-88
68. Witte K, Gruetz G, Volk H, et al. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun. 2009 ; 10: 702-714